![Daniel J. Abrams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel J. Abrams
Oprichter bij Cerebral Therapeutics, Inc.
Actieve functies van Daniel J. Abrams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cerebral Therapeutics, Inc.
![]() Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
Oprichter | - | - | |
President | 01-01-2010 | 24-09-2019 |
Loopbaan van Daniel J. Abrams
Eerdere bekende functies van Daniel J. Abrams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sierra Neuropharmaceuticals, Inc.
![]() Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Directeur/Bestuurslid | 26-06-2009 | 14-04-2010 |
Hoofd Techniek/Wetenschap/O&O | 25-06-2009 | 19-05-2011 | |
Oprichter | 14-04-2010 | 19-05-2011 | |
President | 14-04-2010 | 23-02-2011 | |
University of Colorado Health Sciences Center | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Director/Board Member | 2 |
Founder | 2 |
President | 2 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Sierra Neuropharmaceuticals, Inc.
![]() Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sierra Neuropharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of centrally-administered, small molecule therapeutics for the treatment of severe central nervous systems diseases refractory to oral medications. These include epilepsy, schizophrenia, bipolar disorder, anxiety disorders and major depression. The company uses a proprietary drug development process to reformulate pharmaceuticals for direct delivery to the brain via standard implantable pumps. The company was founded in 2005 and is headquartered in Aurora, CO. | Health Technology |
Cerebral Therapeutics, Inc.
![]() Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Commercial Services |
- Beurs
- Insiders
- Daniel J. Abrams
- Ervaring